.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Novartis
Boehringer Ingelheim
Federal Trade Commission
Julphar
Deloitte
Covington
Johnson and Johnson
Fish and Richardson
Colorcon

Generated: November 22, 2017

DrugPatentWatch Database Preview

RALOXIFENE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Raloxifene Hydrochloride, and when can generic versions of Raloxifene Hydrochloride launch?

Raloxifene Hydrochloride is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Watson Labs Inc, Invagen Pharms, Sciegen Pharms Inc, Glenmark Pharms Ltd, and Teva Pharms Usa. and is included in seven NDAs.

The generic ingredient in RALOXIFENE HYDROCHLORIDE is raloxifene hydrochloride. There are sixteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the raloxifene hydrochloride profile page.

Pharmacology for RALOXIFENE HYDROCHLORIDE

Medical Subject Heading (MeSH) Categories for RALOXIFENE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL208206-001Apr 8, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL078193-001Mar 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL090842-001Sep 24, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL204310-001Aug 28, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL200825-001Jan 21, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL204491-001Mar 22, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sciegen Pharms Inc
RALOXIFENE HYDROCHLORIDE
raloxifene hydrochloride
TABLET;ORAL206384-001Oct 12, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cipla
UBS
Merck
Chubb
Cantor Fitzgerald
Federal Trade Commission
Chinese Patent Office
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot